BACKGROUND. It is suspected that young patients with adenocarcinoma ha
ve a more aggressive form of disease and therefore a poorer prognosis
than older patients. METHODS. A retrospective cohort study used the po
pulation-based tumor registries of Orange, San Diego, and Imperial Cou
nties. Cases (patients age less than or equal to 40 years with gastric
carcinoma) were compared with controls (patients age >40 years with g
astric carcinoma). RESULTS. The overall, age-adjusted incidence rate o
f gastric carcinoma was 10.2/100,000. Approximately 5.5% of 3,020 case
s occurred in patients age <41 years. Young patients (especially white
s and Latinos) were more likely to have distant metastases [45% versus
34%; odds ratio (OR) = 2.6; 95% confidence interval (CI), 1.4-4.8; P
< 0.001]. The histology of young patients (especially Latinos and Asia
ns) was more likely to be signet ring cell (28% versus 15%; OR = 2.3;
95% CI, 1.6-3.3; P < 0.001), and the grade of young patients (especial
ly whites and Latinos) was more likely to be Grade 3 or 4 (according t
o the World Health Organization International Classification of Diseas
es for Oncology; 68% versus 56%; OR = 2.1; 95% CI, 1.4-3.3; P < 0.001)
. The tumors of young patients (especially Asians) were less likely to
be of the gastroesophageal junction (16% versus 27%; OR = 0.47; 95% C
I, 0.31-0.72; P < 0.001) and of the antrum (17% versus 22%; OR = 0.62;
95% CI, 0.41-0.95; P = 0.03) than the gastric body. Younger patients
were more likely to receive chemotherapy (50% versus 28%; OR = 2.7; 95
% CI, 1.9-3.7; P < 0.001). Only patients age >70 years had an independ
ent increased risk of dying from all causes in comparison with young p
atients (relative risk = 1.46; P = 0.01). CONCLUSIONS. Young gastric c
arcinoma patients have adverse clinical and pathologic features in com
parison with older patients. In this study, young age was not found to
be an independent predictor of overall survival. (C) 1998 American Ca
ncer Society.